Accelerated glycoxidation takes part in the development of diabetic complications. We determined advanced glycation end-products (AGEs) and advanced oxidation protein products (AOPP) in the sera of 52 patients with diabetes mellitus (DM) - 18 with DM Type 1 and 34 with DM Type 2 and examined their relationship to the compensation of the disease. AGEs were estimated spectrofluorimetrically (350 nm/440 nm) whereas AOPP were determined spectro-photometrically (340 nm). AGEs were elevated only in DM Type 2 (DM2 5.11+/-1.15 x 10(3) AU/g vs controls 4.08+/-0.71 x 10(3) AU/g, p<0.001, vs DM1 4.14+/-0.86 x 10(3) AU/g, p<0.005, DM1 vs controls were not significant). AOPP were elevated significantly in both types of DM with higher levels in DM Type 2 (DM2 157.50+/-75.15 micromol/l vs healthy subjects 79.80+/-23.72 micromol/l, p<0.001, vs DM1 97.50+/-30.91 micromol/l, p<0.005, DM1 vs controls p<0.05). There was a tight correlation between AGEs and AOPP in both types of DM (DM1 r=0.75, DM2 r=0.47 (p<0.05)) and both AGEs and AOPP correlated with triglycerides. In DM Type 1 only, AGEs correlated with HbA1c r=0.47 (p<0.05) and with blood glucose. Slight but not significant differences in AGEs and AOPP levels were observed in patients with or without diabetic complications. Oxidative stress is increased in both types of DM, more in Type 2 where it contributes to the formation of glycoxidation products.

• MeSH
• diabetes mellitus 1. typu krev   MeSH
• diabetes mellitus 2. typu krev   MeSH
• dospělí MeSH
• krevní proteiny analýza   metabolismus   MeSH
• lidé středního věku MeSH
• lidé MeSH
• oxidace-redukce MeSH
• oxidační stres fyziologie   MeSH
• produkty pokročilé glykace krev   MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• statistika jako téma MeSH
• stupeň závažnosti nemoci MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• klinické zkoušky kontrolované MeSH
• klinické zkoušky MeSH
• práce podpořená grantem MeSH
• srovnávací studie MeSH
• Názvy látek
• krevní proteiny MeSH
• produkty pokročilé glykace MeSH

Chronic renal failure is associated with increased oxidative and carbonyl stresses that contribute to long-term uremic complications. In our study, we determined two markers of these stresses--AGEs (advanced glycation end products) and AOPP (advanced oxidation protein products)--in chronic hemodialysis patients in order to find out their relationship to the dialysis treatment. Plasmas of 20 hemodialyzed patients treated with modified cellulose membranes were examined at 0 and 15 min and at the end (i.e. after 4 h) of the dialysis session. AGEs were estimated using a spectrofluorometric method (excitation 350 nm, emission 440 nm) and are expressed in AU (arbitrary units)/g protein. AOPP were determined spectrophotometrically (absorbance at 340 nm) and are expressed in chloramine units per gram of protein (micromol/g). AOPP decrease slightly from 0 to 15 min of the dialysis procedure (4.0 +/- 1.5 vs. 3.0 +/- 0.9 micromol/g, p < 0.01). However, they are increased at the end of the session (5.0 +/- 2.1 micromol/l vs. 15 min, p < 0.01, not significant vs. beginning). On the other hand, AGEs decrease continuously from the beginning to the end of the session (mainly in the first minutes of the dialysis) (1.52 +/- 0.34 x 10(4) AU/g at 0 min, 1.39 +/- 0.33 x 10(4) AU/g at 15 min, p < 0.001 vs. beginning, 1.30 +/- 0.33 x 10(4) AU/g at the end, p < 0.001 vs. beginning, not significant vs. 15 min). Neither AGEs nor AOPP correlate with the age of hemodialyzed patients and with the number of years of the dialysis treatment. AOPP correlate with AGEs before the dialysis session (r = 0.62, p < 0.05) but not after the session (r = 0.29, not significant). According to our results, AGEs may serve more as a marker of chronic damage while AOPP may better describe acute oxidative stress during the dialysis treatment.

• MeSH
• biologické markery krev   MeSH
• časové faktory MeSH
• chloraminy krev   MeSH
• chronické selhání ledvin krev   terapie   MeSH
• dialýza ledvin škodlivé účinky   MeSH
• fluorescenční spektrometrie MeSH
• lidé středního věku MeSH
• lidé MeSH
• oxidační stres * MeSH
• produkty pokročilé glykace krev   MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• studie případů a kontrol MeSH
• Check Tag
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• biologické markery MeSH
• chloramine MeSH Prohlížeč
• chloraminy MeSH
• produkty pokročilé glykace MeSH

The reduction of ammonia emissions from air was experimentally investigated by advanced oxidation processes (AOPs) utilizing the combination of ultraviolet irradiation with ozone. The influence of operating conditions such as initial ammonia concentration and flow rate of gas on the reduction of ammonia concentration was investigated in homemade photochemical unit. The conversion of ammonia decreased with increasing initial concentration of ammonia and with increasing flow rate of air (decreasing retention time). The highest conversion of ammonia (97%) was achieved under lower initial concentration of ammonia (30 ppm) and lower flow rate of air (28 m3/h). The energy per order was evaluated for the advanced oxidation process too. The energy consumption was about 0.037 kWh/m3/order for the 97% ammonia conversion at 30 ppm of initial ammonia concentration and 28 m3/h flow rate of air. Based on the results, the advanced oxidation process combining the UV irradiation and ozone was effective for mitigation of ammonia concentration and presents a promising technology for the reduction of odor emissions from livestock buildings. Moreover, the AOPs are suitable for application for high flow rate of air, especially for ammonia abatement from livestock buildings, where very high efficiency is expected.

• Klíčová slova
• Advanced oxidation processes, UV irradiation, ammonia, flow reactor, ozone,
• MeSH
• amoniak analýza   chemie   účinky záření   MeSH
• látky znečišťující vzduch analýza   chemie   účinky záření   MeSH
• oxidace-redukce MeSH
• ozon chemie   MeSH
• peroxid vodíku chemie   MeSH
• regenerace a remediace životního prostředí přístrojové vybavení   metody   MeSH
• ultrafialové záření * MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• amoniak MeSH
• látky znečišťující vzduch MeSH
• ozon MeSH
• peroxid vodíku MeSH

OBJECTIVE: Pregnancy and mainly its complications are associated with increased oxidative stress. Advanced oxidation protein products (AOPP) can serve as one of its markers. SETTING: First Institute of Medical Chemistry and Biochemistry and Institute for Clinical Biochemistry, First Medical Faculty, Charles University; Institute for Care of Mother and Child, Prague. METHODS: Together with parameters of prenatal screening, AOPP were measured in the serum of 23 pregnant women in the 2nd trimester of pregnancy. A group of healthy blood donors--women and men was used for comparison. AOPP were determined spectrophotometrically according to Witko-Sarsat (absorbance at 340 nm) and are expressed in chloramin units (mumol/l). RESULTS: Serum AOPP concentrations in pregnant women are significantly higher in comparison with blood donors--women (85.90 +/- 18.70 mumol/l vs 57.34 +/- 16.31 mumol/l, P < 0.0001) but there is no statistically significant difference between pregnant women and blood donors--men (85.90 +/- 18.70 mumol/l vs 78.60 +/- 44.01 mumol/l). AOPP level does not correlate either with the age of pregnant women or with the parameters of prenatal screening (human chorionic gonadotrophin--HCG, alpha-1-fetoprotein--AFP and trophoblast-specific--beta-1-glycoproteion--SP1). CONCLUSION: AOPP as a marker of oxidative stress is increased in the serum of pregnant women in comparison with women--blood donors but is similar as in men--blood donors which supports the hypothesis of hormonal influence. Nevertheless, AOPP do not correlate with the parameters of prenatal screening (HCG, AFP and SP1).

• MeSH
• biologické markery krev   MeSH
• druhý trimestr těhotenství MeSH
• krevní proteiny metabolismus   MeSH
• lidé MeSH
• oxidace-redukce MeSH
• oxidační stres * MeSH
• produkty pokročilé glykace metabolismus   MeSH
• těhotenství metabolismus   MeSH
• Check Tag
• lidé MeSH
• mužské pohlaví MeSH
• těhotenství metabolismus   MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• biologické markery MeSH
• krevní proteiny MeSH
• produkty pokročilé glykace MeSH

The feasibility of using advanced oxidation processes (AOPs) for abatement of ammonia from livestock buildings was examined in a series of pilot plant experiments. In this study, all the experiments were conducted in a two-step unit containing a dry photolytic reactor (UV185/UV254/O3) and a photochemical scrubber (UV254/H2O2). The unit efficiency was tested for two initial ammonia concentrations (20 and 35 ppmv) and three different air flows (150, 300 and 450 m3·h-1). While the first step removes mainly organic pollutants that are often present together with ammonia in the air and ammonia only partially, the second step removes around 90% of ammonia emissions even at the highest flow rate of 450 m3·h-1. Absorbed ammonia in the aqueous phase can be effectively removed without adjusting the pH (i.e. without the addition of other additives) using UV and ozone. Complete removal of ammonia was achieved after 15 h of irradiation. In order to assess the price efficiency of the suggested technology and to be able to compare it with other methods the figures-of-merit were determined. The price needed for lowering ammonia emission by one order of magnitude is 0.002 € per cubic meter of treated air at the highest flow rate of 450 m3·h-1 and for initial ammonia concentrations of 20 ppmv. These findings demonstrate that AOPs are a promising method for ammonia abatement from livestock buildings which are rarely using any waste air treatment method.

• Klíčová slova
• Advanced oxidation processes, Ammonia emissions, Hydrogen peroxide, Hydroxyl radical, Ozone,
• Publikační typ
• časopisecké články MeSH

BACKGROUND: The aim of the study was to assess the contribution of carbonyl and oxidative stresses to the development of amyloidosis in patients suffering from chronic rheumatic diseases, and the potential influence of renal function to their concentrations was considered. METHODS: We investigated 17 patients with chronic rheumatological diseases and histologically proven diagnosis of AA amyloidosis (group AA-RA), 26 patients suffering from rheumatoid arthritis without any signs of AA amyloidosis (group nonAA-RA) and 20 healthy volunteers (Co). In all patients, advanced glycation end products (AGEs), advanced oxidation protein products (AOPP), pregnancy-associated plasma protein A (PAPP-A) and other selected proinflammatory markers were measured. RESULTS: An increase in serum levels of AOPP and AGEs was found in the AA-RA group in comparison with nonAA-RA patients and also with Co (p < 0.001 for all comparisons). AGEs positively correlated with serum creatinine (r = 0.67, p = 0.004) and negatively with glomerular filtration rate (r = -0.54, p = 0.027). We did not find a correlation between AOPP and any other assessed parameters including proteins and renal parameters. PAPP-A levels were not significantly increased in any group of patients (AA-RA, nonAA-RA) in comparison with Co. CONCLUSIONS: Increased plasma levels of AGEs and AOPP in the group of patients with AA-RA may have been partly explained by the diminished renal clearance. However, the increase in AOPP levels was higher than what is expected in this degree of renal failure (glomerular filtration rate in the AA-RA group corresponding to chronic kidney disease stage III).

• MeSH
• amyloidóza krev   etiologie   MeSH
• biologické markery krev   MeSH
• chronická nemoc MeSH
• cytokiny krev   MeSH
• glykosylace MeSH
• kohortové studie MeSH
• ledviny patofyziologie   MeSH
• lidé středního věku MeSH
• lidé MeSH
• oxidace-redukce MeSH
• oxidační stres MeSH
• receptor pro konečné produkty pokročilé glykace MeSH
• receptory imunologické krev   MeSH
• revmatické nemoci krev   komplikace   patofyziologie   MeSH
• senioři MeSH
• těhotenský plazmatický protein A metabolismus   MeSH
• vyšetření funkce ledvin MeSH
• zánět krev   MeSH
• Check Tag
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• biologické markery MeSH
• cytokiny MeSH
• receptor pro konečné produkty pokročilé glykace MeSH
• receptory imunologické MeSH
• těhotenský plazmatický protein A MeSH

BACKGROUND: Oxidative stress can potentiate atherogenesis via modification of biological structures and formation of new compounds, e.g. advanced glycation end products (AGEs) and advanced oxidation protein products (AOPP). The aim of the study was to determine AGEs and AOPP in patients with atherosclerosis, effect of statin therapy and relationship to parameters of lipid metabolism. METHODS AND RESULTS: AGEs (carboxymethyllysine - ELISA and fluorescent AGEs - spectrofluorimetry) and AOPP (spectrophotometry) were assessed in 42 patients with atherosclerosis and 21 healthy controls. AGEs are significantly elevated in patients with atherosclerosis in comparison with healthy subjects (carboxymethyllysine 9.02+/-1.66 microg/g prot. vs 7.52+/-1.18 microg/g prot., p<0.001, fluorescent AGEs 4.39 x 103+/-1.15 x 103 AU/g prot. vs 3.78 x 103+/-0.52 x 103 AU/g prot., p<0.001). Mean AOPP concentrations are also slightly higher, but this elevation is not quite significant (95.0+/-42.9 micromol/l vs 79.7+/-28.2 micromol/l, p=0.096). AGEs and AOPP correlate significantly with each other and with selected lipids. Patients with atherosclerosis treated with statins have slightly lower CML, AGEs and AOPP (it did not reach the statistical significance). CONCLUSIONS: Advanced glycoxidation products are elevated in patients with atherosclerosis and are related to parameters of lipid metabolism. Glycoxidation might be possibly therapeutically influenced by statins; however, further clinical studies are required to confirm this hypothesis.

• MeSH
• arterioskleróza krev   farmakoterapie   MeSH
• krevní proteiny metabolismus   MeSH
• lidé středního věku MeSH
• lidé MeSH
• lysin analogy a deriváty   krev   MeSH
• oxidace-redukce * MeSH
• produkty pokročilé glykace krev   MeSH
• Check Tag
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• krevní proteiny MeSH
• lysin MeSH
• N(6)-carboxymethyllysine MeSH Prohlížeč
• produkty pokročilé glykace MeSH

Oxidative stress, which is characterized as dysbalance between free radicals and antioxidants in favour of radicals, participates in the pathogenesis of many diseases and their complications. Carbonyl stress is closely related to oxidative stress and is described as increase of reactive carbonyl compounds caused by their increased formation or decreased degradation and clearance. Both oxidative and carbonyl stresses cause damage to proteins--they lead to formation of advanced oxidation protein products--AOPP, advanced glycation end-products--AGEs and advanced lipoperoxidation end-products--ALEs. These compounds have several biological effects--e.g. stimulation of secretion of cytokines, adhesive molecules and growth factors and take part in the development of complications of diabetes mellitus and chronic renal failure.

• MeSH
• lidé MeSH
• oxidace-redukce MeSH
• oxidační stres * MeSH
• peroxidace lipidů * MeSH
• produkty pokročilé glykace metabolismus   MeSH
• proteiny metabolismus   MeSH
• zvířata MeSH
• Check Tag
• lidé MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• přehledy MeSH
• Názvy látek
• produkty pokročilé glykace MeSH
• proteiny MeSH

Several diseases (atherosclerosis, diabetes mellitus, chronic renal failure) are associated with oxidative and carbonyl stress, microinflammation and eventually autoimmune reaction. Both oxidative and carbonyl stress cause damage to important biological structures-proteins, carbohydrates, lipids and nucleic acids and may enhance inflammatory response. New compounds and modified structures are formed, among them advanced oxidation protein products (AOPP), advanced glycation end products (AGEs-e.g. pentosidine, carboxymethyllysine) and advanced lipoperoxidation end products (ALEs). Accumulation of glycoxidation products, upregulation of protective mechanisms like glyoxalase I as well as enhanced transcription of genes coding for cytokines, growth factors and adhesive molecules via AGE-RAGE (receptor for AGEs) interaction and subsequent increase of classical acute phase reactants (e.g. CRP-C-reactive protein or orosomucoid) can be observed in a variety of chronic diseases. Additionally, several RAGE gene polymorphisms have shown association with some pathological states-diabetic complications, vascular damage, inflammatory response or antioxidant status. Recent advances in understanding the pathogenesis of chronic diseases provide new possibilities for diagnostics and monitoring of severely ill patients, however, further studies are still required to establish efficient therapeutical strategies.

• MeSH
• chronická nemoc * MeSH
• chronické selhání ledvin komplikace   metabolismus   MeSH
• diabetes mellitus genetika   metabolismus   MeSH
• klinická chemie metody   MeSH
• laktoylglutathionlyasa genetika   metabolismus   MeSH
• lidé MeSH
• nukleotidy metabolismus   MeSH
• oxidace-redukce MeSH
• oxidační stres MeSH
• polymorfismus genetický MeSH
• produkty pokročilé glykace analýza   metabolismus   MeSH
• receptor pro konečné produkty pokročilé glykace MeSH
• receptory cytoplazmatické a nukleární metabolismus   MeSH
• receptory imunologické genetika   metabolismus   MeSH
• zánět etiologie   metabolismus   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• přehledy MeSH
• Názvy látek
• laktoylglutathionlyasa MeSH
• nukleotidy MeSH
• produkty pokročilé glykace MeSH
• receptor pro konečné produkty pokročilé glykace MeSH
• receptory cytoplazmatické a nukleární MeSH
• receptory imunologické MeSH

Obstructive sleep apnea (OSA) is a risk factor of hypertension, coronary artery disease and stroke. OSA is also considered a cause of accelerated atherogenesis. Advanced oxidation protein products (AOPP) are among the biochemical indicators of higher risk of atherogenesis as an independent risk factor for coronary artery disease. 20 men suffering from OSA were examined using night polygraphy, the AOPP were determined from their morning blood samples. The mean AOPP concentration in the patients group was 91.8 (SD=42.3) micromol/l, in the control group 76.2 (SD=35.3) pmol/l, the difference was not significant. The AOPP were found correlated with the AHI (apnoe/hypopnoe index) (R=0.485, P=0.030). The results support the hypothesis that OSA increases the oxidative stress and atherogenesis.

• MeSH
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• obstrukční spánková apnoe krev   MeSH
• oxidační stres * MeSH
• senioři MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH